NAFLD |
non-alcoholic fatty liver disease |
NAFL |
non-alcoholic fatty liver |
NASH |
non-alcoholic steato-hepatitis |
T2DM |
type-2 diabetes mellitus |
GI |
gastro-intestinal |
TJ |
tight-junctions |
kDa |
kiloDalton |
TEER |
transepithelial electric resistance |
EVOM |
epithelial volt/ohm meter |
FABP |
fatty acid binding protein |
i-FABP |
intestinal FABP |
CHB |
chronic hepatitis B |
CHC |
chronic hepatitis C |
LPS |
lipopolysaccharide |
PAMPs |
pathogen-associated molecular patterns |
DAMPs |
damage-associated molecular patterns |
TFG-β |
transforming growth factor-beta |
IL-1 |
interleukin-1 |
IL-6 |
interleukin-6 |
TNF-α |
tumour necrosis factor-alpha |
TLR-4 |
toll-like receptor 4 |
GLP-2 |
glucagon-like peptide 2 |
GLUT-2 |
glucose transporter-2 |
BMI |
body mass index |
IL-1β |
interleukin-1 beta |
SCFA |
short chain fatty acid |
FMT |
faecal microbiota transplant |